Case | Study | Â | Reported Number of Cases | Age(yr) | sex | Location | Helicobacter pylori Infection | Ig light chain of Mott cells | Other Conditions | Follow up | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Tazawa et al. [1] | 1998 | 1 | 53 | M | Stomach | Yes | Polyclonal | Alcoholic cirrhosis of the liver | almost absent RB after radical treatment of HP | ||||
2 | Erbersdobler et al. [23] | 2004 | 1 | 80 | F | Stomach | No | Polyclonal | Candida esophagitis, history of psychosis | NS | ||||
3 | Ensari et al. [24] | 2005 | 1 | 70 | M | Stomach | Yes | Polyclonal | Hypertension | NS | ||||
4 | Drut et al. [25] | 2006 | 1 | 34 | M | Stomach | No | Polyclonal | HIV+, Alcohol abuse | NS | ||||
5 | Wolkersdörfer et al. [26] | 2006 | 1 | 54 | M | Stomach | Yes | Polyclonal | MGUS | NS | ||||
6 | Paik et al. [27] | 2006 | 2 | 47 | F | Stomach | Yes | Polyclonal | CG | almost absent RB after radical treatment of HP | ||||
7 | Â | Â | Â | 35 | F | Stomach | Yes | Polyclonal | CG | almost absent RB after radical treatment of HP | ||||
8 | Pizzolitto et al. [28] | 2007 | 1 | 60 | F | Stomach | Yes | Polyclonal,PAS(+) | CG | almost absent RB after radical treatment of HP | ||||
9 | Eum et al. [29] | 2007 | 1 | 48 | M | Stomach | Yes | NS | CP | NS | ||||
10 | Licci et al. [30] | 2009 | 1 | 59 | M | Stomach | Yes | Polyclonal | HIV+ | almost absent RB after radical treatment of HP | ||||
11 | Habib et al. [31] | 2010 | 1 | 75 | M | Stomach | No | Polyclonal | Hyperlipidemia,Rhabdomyolysis | NS | ||||
12 | Shinozaki et al. [32] | 2010 | 2 | 74 | M | Stomach | Yes | Polyclonal | EBVAGC | NS | ||||
13 | Â | Â | Â | 29 | F | Stomach | Yes | Polyclonal | EBVAGC | NS | ||||
14 | Del Gobbo et al. [33] | 2011 | 1 | 78 | F | Stomach | No | Polyclonal | CG | NS | ||||
15 | Wolf et al. [34] | 2011 | 1 | 67 | M | Stomach | Yes | NS | Signet-ring cell carcinoma | NS | ||||
16 | Yoon et al. [35] | 2012 | 2 | 57 | M | Stomach | Yes | Polyclonal | GP,CP | almost absent RB after radical treatment of HP | ||||
17 | Â | Â | Â | 43 | M | Stomach | Yes | Polyclonal | CG | almost absent RB after radical treatment of HP | ||||
18 | Bhalla et al. [36] | 2012 | 1 | 82 | M | Stomach | No | Polyclonal | HIV+ | NS | ||||
19 | Coyne et al. [37] | 2012 | 1 | 49 | M | Stomach | No | Monoclonal (κ) | Hepatitis c | NS | ||||
20 | Karabagli et al. [38] | 2012 | 1 | 60 | M | Stomach | Yes | Polyclonal | CG | NS | ||||
21 | Choi et al. [39] | 2012 | 1 | 55 | M | Stomach | Yes | NS | GC | NS | ||||
22 | Miura et al. [40] | 2012 | 1 | 63 | F | Stomach | Yes | Monoclonal (κ) | CG,Hyperlipidemia | NS | ||||
23 | Araki et al. [41] | 2013 | 1 | 74 | F | Stomach | Yes | Monoclonal (κ) | Alzheimer’s disease, Stomach ulcers | NS | ||||
24 | Zhang et al. [12] | 2014 | 9 | 78 | F | Stomach | No | Monoclonal (κ) | NS | Clinical followup evaluations were uneventful | ||||
25 |  |  |  | 77 | F | Stomach | Yes | Monoclonal (κ) | NS | NS | ||||
26 |  |  |  | 77 | F | Stomach | Yes | Monoclonal (κ) | CP | NS | ||||
27 |  |  |  | 56 | M | Stomach | Yes | Monoclonal (κ) | CP | NS | ||||
28 |  |  |  | 76 | M | Stomach | Yes | Monoclonal (κ) | NS | NS | ||||
29 |  |  |  | 50 | M | Stomach | Yes | Monoclonal (κ) | NS | NS | ||||
30 |  |  |  | 28 | M | Stomach | No | Monoclonal (κ) | NS | NS | ||||
31 |  |  |  | 24 | F | Stomach | No | Monoclonal (κ) | NS | NS | ||||
32 | Â | Â | Â | 66 | M | Stomach | No | NS | NS | NS | ||||
33 | Antunes et al. [42] | 2016 | 1 | 79 | F | Stomach | No | NS | GERD | NS | ||||
34 | Nishimura et al. [43] | 2016 | 1 | 64 | F | Stomach | Yes | Polyclonal | Bronchiectasis | almost absent RB after radical treatment of HP | ||||
35 | Imai et al. [44] | 2016 | 1 | 64 | M | Stomach | No | Polyclonal | Eosinophilia | NS | ||||
36 | Zhang et al. [45] | 2016 | 1 | 69 | M | Stomach | Yes | Monoclonal (κ) | Hypertension | NS | ||||
37 | Yorita et al. [46] | 2017 | 1 | 86 | M | Stomach | Yes | Monoclonal (κ) | Rheumatoid arthritis | NS | ||||
38 | Cengiz Peker et al. [47] | 2017 | 2 | 39 | M | Stomach | Yes | Polyclonal | CG | NS | ||||
39 | Â | Â | Â | 51 | F | Stomach | Yes | Polyclonal | CG | NS | ||||
40 | Trna et al. [48] | 2017 | 1 | 77 | M | Stomach, heart | NS | NS | NS | Follow-up endoscopy with biopsies–without any difference | ||||
41 | Altindag et al. [16] | 2019 | 11 | 81 | F | Stomach | No | Polyclonal | Multiple myeloma | Histology report revealed increased distribution in RBs in followup endoscopy | ||||
43 | Â | Â | Â | 84 | M | Stomach | Yes | Polyclonal | NS | NS | ||||
44 | Â | Â | Â | 64 | M | Stomach | Yes | Polyclonal | NS | NS | ||||
45 | Â | Â | Â | 71 | M | Stomach | Yes | Polyclonal | NS | NS | ||||
46 | Â | Â | Â | 79 | F | Stomach | No | Polyclonal | Gastric polyps | NS | ||||
47 | Â | Â | Â | 77 | F | Stomach | Yes | Polyclonal | Adenocarcinoma | NS | ||||
48 | Â | Â | Â | 44 | F | Stomach | Yes | Polyclonal | NS | NS | ||||
49 | Â | Â | Â | 72 | M | Stomach | No | Polyclonal | NS | NS | ||||
50 | Â | Â | Â | 64 | M | Stomach | No | Polyclonal | CP | NS | ||||
51 | Â | Â | Â | 87 | F | Stomach | Yes | Polyclonal | NS | NS | ||||
52 | Qiao et al. [49] | 2019 | 1 | 28 | M | Stomach | No | Polyclonal | HIV+ | NS | ||||
53 | Umakoshi et al. [50] | 2020 | 1 | 81 | F | Stomach(multifocal) | Yes | Polyclonal | Hepatitis c | NS | ||||
54 | Yalcin et al. [51] | 2020 | 1 | 55 | M | Stomach | Yes | Polyclonal | CG | almost absent RB after radical treatment of HP | ||||
55 | Peruhova et al. [52] | 2020 | 1 | 51 | M | Stomach | No | Polyclonal | CG,Iron deficiency anemia | Without endoscopic improvement, histology report showeddecreased RB in second followup and almost absent RB in third follow-up | ||||
56 | Bozhkova et al. [53] | 2021 | 1 | 60 | F | Stomach | Yes | Polyclonal | Malignant gastric stromal tumor | NS | ||||
57 | Present study | Â | 1 | 50 | M | Stomach | Yes | Polyclonal | Irritable bowel syndrome | almost absent RB after radical treatment of HP |